secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K/A
Filed at:   2026-09-10T20:30:24+00:00
Accession:  0001213900-26-098820
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 4.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative dismisses CBIZ, hires Bush CPA; audit committee probe ongoing
----------------------------------------------------------------------------

- Dismissed CBIZ as auditor effective Aug 28, 2026; board approved Aug 26, audit committee ratified Sep 1.
- CBIZ flagged possible reportable event under Item 304(a)(1)(v)(C) tied to suspended ExoCR/BioX product lines.
- CBIZ's FY2025 report included going-concern doubt; no disagreements on accounting principles.
- Engaged Bush & Associates CPA to audit FY2024-2026; no prior consultations with Bush.
- Audit committee hired independent investigator Aug 14; no material findings yet, investigation ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026098820/0001213900-26-098820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026098820/ea0305107-8ka_biore.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-098820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer